Spinach® vapes, known for exceptional quality, bold flavor profiles and advanced hardware, continue to resonate with adult ...

Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

Short-seller Andrew Left is on trial in Los Angeles for securities fraud, accused of market manipulation through misleading ...

Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

Cronos Group Inc (NASDAQ:CRON) is one of the best CBD stocks to buy right now. The stock is up roughly 40% over the past year ...

For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...

Investors are clamoring to invest in publicly-traded cannabis companies as the legal marijuana market expands. Despite the clear growth potential in this industry, investors still need to exercise ...

Shares of Cronos Group Inc. CRON rallied 1.09% to $2.77 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.86% to ...

TORONTO, March 16, 2026 (GLOBE NEWSWIRE)-- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...

Detailed price information for Cronos Group Inc (CRON-Q) from The Globe and Mail including charting and trades.

Cronos Group Inc (NASDAQ:CRON) shares are trading lower by 2.78% to $2.63 during Tuesday’s session. Shares of cannabis stocks are trading lower in sympathy with Tilray, which fell after reporting ...